ORMP Stock Summary and Trading Ideas (Oramed Pharmaceuticals | NASDAQ:ORMP)

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

Oramed Pharmaceuticals trades on the NASDAQ stock market under the symbol ORMP.

As of April 24, 2024, ORMP stock price climbed to $2.37 with 40,833 million shares trading.

ORMP has a beta of 1.87, meaning it tends to be more sensitive to market movements. ORMP has a correlation of 0.10 to the broad based SPY ETF.

ORMP has a market cap of $96.03 million. This is considered a Micro Cap stock.

Last quarter Oramed Pharmaceuticals reported $0 in Revenue and $.33 earnings per share. This met revenue expectation and exceeded earnings estimates by $.45.

In the last 3 years, ORMP stock traded as high as $31.54 and as low as $1.67.

The top ETF exchange traded funds that ORMP belongs to (by Net Assets): IWC, SPDW, AVSC, GWX, DFAS.

ORMP has underperformed the market in the last year with a price return of +3.0% while the SPY ETF gained +24.2%. ORMP has also underperformed the stock market ETF in the last 3 month and 2 week periods returning +3.5% and -11.9%, respectively, while the SPY returned +4.6% and -2.7%, respectively.

ORMP support price is $2.25 and resistance is $2.45 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ORMP stock will trade within this expected range on the day.